Arbutus Biopharma (ABUS) Stock Price Today, Chart, Quote and News | baraka

A

Arbutus Biopharma (ABUS)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About Arbutus Biopharma (ABUS)

Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing cure for people with chronic hepatitis B virus (HBV) infection. Its product pipeline is focused on find... Read more

Open
USD2.75
High
USD2.80
Low
USD2.74
52 Week High
USD3.29
Monthly Return
9.60%
Revenue
24M

Daily Vol.
133.02k
Avg. Daily Vol.
1.97M
Market Cap.
492M
52 Week Low
1.69
Annual Return
7.90%

Stock News

ICE to Provide OTC Derivatives Pricing and Risk Management Solution to Multinational Mining and Metallurgy Company Eramet S.A.

ICE to Provide OTC Derivatives Pricing and Risk Management Solution to Multinational Mining and Metallurgy Company Eramet S.A.

Yahoo

These 3 Dividend Payers Are Forever Stocks, Even if the Market Crumbles

These 3 Dividend Payers Are Forever Stocks, Even if the Market Crumbles

Yahoo

3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole

3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole

Yahoo

Immutep Quarterly Activities Report Q3 FY24

Immutep Quarterly Activities Report Q3 FY24

Yahoo

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.